Contact Us
Drug Search Results
More Filters [+]

BIRT-2584

Alternative Names: birt-2584, birt2584, birt 2584
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

LFA-1 inhibitor

Mechanisms of Action: LFA1 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Boehringer Ingelheim
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BIRT-2584

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Psoriasis|Multiple Sclerosis

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2007-004328-18

P2

Completed

Psoriasis

2008-06-09

NCT00333411

P2

Completed

Psoriasis

2008-06-01

2005-005368-10

P2

Terminated

Psoriasis

2007-05-03

2005-005985-35

P2

Completed

Multiple Sclerosis

2007-02-09

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Human Serum Albumin Immobilized On Magnetizable Beads: A Rapid Method for Compound HSA Binding Study.

12/01/2021

PubMed

 HLM-beads: Rapid Assessment of Nonspecific Binding to Human Liver Microsomes Using Magnetizable Beads.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions